Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Interest Coverage Ratio (2022 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Interest Coverage Ratio for 4 consecutive years, with 10.2 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio fell 34.64% to 10.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 9.33 through Dec 2025, up 29.56% year-over-year, with the annual reading at 9.33 for FY2025, 27.61% up from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 10.2 at Rhythm Pharmaceuticals, up from 11.1 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 7.57 in Q4 2024, with the low at 980.35 in Q2 2022.
  • Average Interest Coverage Ratio over 4 years is 77.26, with a median of 11.1 recorded in 2025.
  • The sharpest move saw Interest Coverage Ratio surged 98.56% in 2023, then plummeted 71.43% in 2024.
  • Over 4 years, Interest Coverage Ratio stood at 13.98 in 2022, then surged by 35.14% to 9.07 in 2023, then rose by 16.49% to 7.57 in 2024, then plummeted by 34.64% to 10.2 in 2025.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 10.2, 11.1, and 7.79 for Q4 2025, Q3 2025, and Q2 2025 respectively.